This episode examines the barriers to accessing HER2-targeted therapies for non-small cell lung cancer (NSCLC) and strategies ...

Experts discuss the FDA's Accelerated Approval Program, emphasizing its role in providing earlier access to innovative cancer therapies for patients. This episode focuses on the strategies for ...

Vishal A. Patel, MD, explains that delayed skin cancer diagnoses contribute to more advanced disease and poorer outcomes in ...

PBM reforms, Medicare Advantage trends, TrumpRx launch, and Express Scripts settlement highlight key shifts in drug pricing, ...

Multiple myeloma was once viewed as an incurable diagnosis, but Ameet Patel, MD, of Florida Cancer Specialists & Research ...

Vishal A. Patel, MD, is an associate professor of dermatology at the GW School of Medicine & Health Sciences and the director ...

MicroRNAs are central regulators of DLBCL biology and show strong potential as minimally invasive biomarkers to improve ...

Experts discuss the importance of transitioning cancer care from academic centers to community settings, ensuring effective ...

Panelist and director of the leukemia program at Massachusetts General Hospital, Amir Fathi, MD, explained that catchment ...

A universal policy providing free prescription drugs to seniors in Poland significantly reduced out-of-pocket spending and sharply lowered the risk of catastrophic health expenditures, but it may also ...

With medically integrated dispensing (MID) models, pharmacists are more embedded in care and engage more frequently with patients, according to Kenneth Komorny, PharmD, BCPS, of Moffitt Cancer Center.

Osama Abdelghany, PharmD, explains how medically integrated dispensing improves oncology workflows, patient access, and outcomes through EMR-driven care. Medically integrated dispensing (MID) has the ...